Table 2– Mortality assessment of chronic obstructive pulmonary disease patients hospitalised with community-acquired pneumonia according to prior cardiovascular disease status
MortalityPrior cardiovascular diseaseUnadjustedAdjusted#
NoYesHR (95% CI)p-valueHR (95% CI)p-value
30-day782 (11.3)1263 (12.3)1.10 (1.01–1.20)0.0421.18 (0.73–1.10)0.3
90-day1342 (19.4)2164 (21.1)1.10 (1.03–1.18)0.0071.25 (1.03–1.53)0.02
6-month1800 (26.1)2969 (29.0)1.13 (1.06–1.20)<0.0011.27 (1.07–1.50)0.006
12-month2380 (34.5)4012 (39.2)1.17 (1.11–1.23)<0.0011.34 (1.16–1.54)<0.001
  • Data are presented as n (%), unless otherwise stated. HR: hazard ratio. #: potential confounders, with p-values <0.1 in the univariate analyses, were age, race, marital status, smoker, alcohol abuse, peripheral vascular disorder, hemiplegia, diabetes (complicated and uncomplicated), malignancy, metastatic cancer, cerebrovascular disease and cardiovascular or diabetes medications.